Search

Search Results

• THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA Human platelet antigen and immune thrombocytopenia

  Cih-En Huang, Yi-Yang Chen, Jung-Jung Chang, Yu-Ying Wu, Wei-Ming Chen, Ying-Hsuan Wang, Min-Chi Chen, Chang-Hsien Lu, Chung-Sheng Shi, Chih-Cheng Chen

  e2023030

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.030

  1316

  PDF: 1084

  Suppl. Files: 508

  HTML: 403

• MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman

  Davide Matino, Paul Tieu, Dr., Antony Chan

  e2020001

  2020-01-01

  https://doi.org/10.4084/mjhid.2020.001

  3634

  PDF: 1720

  HTML: 749

• Impact of Donor-Specific anti-HLA antibodies and donor KIR characteristics in haploidentical HSCT for beta-Thalassemia

  Marco Andreani, Manuela Testi, Pietro Sodani, Maria Troiano, Andrea Di Luzio, Giuseppe Testa, Michela Falco, Elvira Poggi, Javid Gaziev, Antonina Piazza

  e2017020

  2017-03-01

  https://doi.org/10.4084/mjhid.2017.020

  3194

  PDF: 1043

  HTML: 566

• ALLOIMMUNIZATION IN PATIENTS WITH SICKLE CELL DISEASE AND THALASSAEMIA: EXPERIENCE OF SINGLE CENTRE FROM OMAN

  Anil Pathare, Salam Alkindi

  e2017013

  2017-02-15

  https://doi.org/10.4084/mjhid.2017.013

  2911

  PDF: 1392

  HTML: 1895

• VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES

  Sanaa M. Kamal, Sara Mahmoud, Tamer Hafez, Runia EL Fouly

  e2010001

  2010-02-09

  https://doi.org/10.4084/mjhid.2010.001

  1361

  PDF: 722

  HTML: 7820

• HIV-ASSOCIATED VENOUS THROMBOEMBOLISM

  Michele Bibas, Gianluigi Biava, Andrea Antinori

  e2011030

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.030

  4722

  PDF: 1590

  HTML: 8561

• Guest Edtor: Pellegrino Musto NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES

  Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Erika Morsia, Antonella Poloni, Massimo Offidani

  e2025027

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.027

  1593

  PDF: 1357

  HTML: 789

• CAUSAL RELATIONSHIP BETWEEN HELICOBACTER PYLORI ANTIBODIES AND IMMUNE THROMBOCYTOPENIA: A MENDELIAN RANDOMIZATION STUDY

  Yuzhan Chen, Qitian Mu, Guifang Ouyang

  e2025.003

  2024-12-31

  https://doi.org/10.4084/MJHID.2025.003

  1870

  PDF: 1361

  PDF: 963

  HTML: 378

• DEVELOPMENT OF AN IMPROVED EPSTEIN-BARR VIRUS (EBV) NEUTRALIZING ANTIBODY ASSAY TO FACILITATE DEVELOPMENT OF A PROPHYLACTIC GP350-SUBUNIT EBV VACCINE

  Hui Liu, Lorraine Gemmell, Rui Lin, Fengrong Zuo, Henry H. Balfour, Jr., Jennifer C. Woo, Gregory M. Hayes

  e2020016

  2020-02-26

  https://doi.org/10.4084/mjhid.2020.016

  2091

  PDF: 1174

  HTML: 451

• CLINICAL SIGNS AND TREATMENT OF NEW-ONSET BONE MARROW FAILURE ASSOCIATED SARS-COV-2 INFECTION IN CHILDREN : A SINGLE INSTITUTION PROSPECTIVE COHORT STUD

  Mervat A M youssef, Ebtisam Shawky hmed, Dalia Tarik Kamal, khalid Elsayh,, Mai A Abdelfatta, Hyam Hassan Mahran Mahran, Mostafa M Embaby

  e2024034

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.034

  1354

  PDF: 1440

  HTML: 146

• Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA

  Bhavya S Doshi, Valder R Arruda, Valder R Arruda

  e2020069

  2020-09-08

  https://doi.org/10.4084/mjhid.2020.069

  2360

  PDF: 2039

  HTML: 541

• DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS

  HADI YASSINE

  e2022076

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.076

  1725

  PDF: 1264

  HTML: 459

  Suppl. Figure: 229

  Suppl. Tables: 257

• Transfusion-related acute lung injury (TRALI) in two thalassaemia patients caused by the same multiparous blood donor

  George J Kontoghiorghes

  e2017060

  2017-10-18

  https://doi.org/10.4084/mjhid.2017.060

  2489

  PDF: 735

  HTML: 888

• Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA

  Michele Puppi, Ilaria Sacchetti, Katia Mancuso, Paola Tacchetti, Lucia Pantani, ilaria Rizzello, Miriam Iezza, Marco Talarico, Enrica Manzato, Simone Masci, Roberta Restuccia, Simona Barbato, Silvia Armuzzi, Barbara Taurisano, Ilaria Vigliotta, Elena Zamagni

  e2025045

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.045

  1896

  PDF: 1443

  HTML: 673

• Graves’ disease thyrotoxicosis and propylthiouracil related agranulocytosis successfully treated with therapeutic plasma exchange and g-csf followed by total thyroidectomy.

  Anna Candoni

  e2017058

  2017-10-16

  https://doi.org/10.4084/mjhid.2017.058

  3129

  PDF: 959

  HTML: 1450

  Fig.1: 223

  Fig.2: 222

• MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS

  Elena Maino, Anna Maria Scattolin, Piera Viero, Rosaria Sancetta, Anna Pascarella, Michele Vespignani, Renato Bassan

  e2015001

  2015-01-01

  https://doi.org/10.4084/mjhid.2015.001

  2519

  PDF: 1409

  HTML: 17241

  Bassan Fig.1: 188

  Bassan Fig.2: 292

  Bassan Fig.4: 176

  Fig.3: 310

• Low incidence of anti-pf4/heparin antibodies in patients with acute myelogenous leukemia.

  Håkon Reikvam, Ingvild Jenssen Lægreid, Ingvild Hausberg Sørvoll, Tom Sollid, Trude Victoria Mørtberg, Maria Therese Ahlén, Silje Johansen

  e2024057

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.057

  1058

  PDF: 969

  HTML: 352

• SUCCESSFUL LONG TERM ERADICATION OF FACTOR VIII INHIBITOR IN PATIENTS WITH ACQUIRED HAEMOPHILIA A IN SAUDI ARABIA

  Galila F Zaher, Soheir S Adam

  e2012021

  2012-04-02

  https://doi.org/10.4084/mjhid.2012.021

  1502

  PDF: 982

  HTML: 3764

• IS THE INCIDENCE TREND OF HEPARIN-INDUCED THROMBOCYTOPENIA DECREASED BY THE INCREASED USE OF LOW-MOLECULAR-WEIGHT-HEPARIN?

  Fahad Al-Eidan

  e2015029

  2015-04-19

  https://doi.org/10.4084/mjhid.2015.029

  1908

  PDF: 884

  HTML: 1530

• SEROPOSITIVITY OF HEPATITIS B AND C AMONG SYRIAN MULTITRANSFUSED PATIENTS WITH HEMOGLOBINOPATHY

  Widad Yazaji, Wafa Habbal, Fawza Monem

  e2016046

  2016-09-01

  https://doi.org/10.4084/mjhid.2016.046

  3635

  PDF: 833

  HTML: 1136

  Cover Letter: 248

• TRANSFUSION PRACTICE, POST-TRANSFUSION COMPLICATIONS AND RISK FACTORS IN SICKLE CELL DISEASE IN SENEGAL, WEST AFRICA.

  Moussa Seck, Alioune Badara Senghor, Mossane Loum, Sokhna Aissatou Touré, Blaise Félix Faye, Alioune Badara Diallo, Mohamed Keita, Elimane Seydi Bousso, Sérigne Mourtalla Guèye, Macoura Gadji, Abibatou Sall, Awa Oumar Touré, Saliou Diop

  e2022004

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.004

  2200

  PDF: 1243

  HTML: 492

• ASSESSMENT OF OBESITY AND HEPATIC LATE ADVERSE EFFECTS IN THE EGYPTIAN SURVIVORS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA: SINGLE CENTER STUDY

  Farida El-Rashedy, Mahmoud Ahmed El-Hawy, Sally El Hefnawy, Mona Mohammed

  e2017026

  2017-04-15

  https://doi.org/10.4084/mjhid.2017.026

  2655

  PDF: 1007

  HTML: 1462

  Untitled: 288

• THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION

  Sumit Dahal, Smrity Upadhyay, Rashmi Banjade, Prajwal Dhakal, Navin Khanal, Vijaya Raj Bhatt

  e2017019

  2017-03-01

  https://doi.org/10.4084/mjhid.2017.019

  4445

  PDF: 2122

  HTML: 1978

• THE USE OF MONOCLONAL ANTIBODIES IN THE TREATMENT OF AUTOIMMUNE COMPLICATIONS OF CHRONIC LYMPHOCYTIC LEUKEMIA

  Luca Laurenti

  e2013027

  2013-04-10

  https://doi.org/10.4084/mjhid.2013.027

  2424

  PDF: 1120

  HTML: 2785

• EBV CHRONIC INFECTIONS

  Eligio Pizzigallo, Delia Racciatti, Valeria Gorgoretti

  e2010022

  2010-08-09

  https://doi.org/10.4084/mjhid.2010.022

  3752

  PDF: 1738

  HTML: 8006

• AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS

  Pavankumar Tandra, Jairam Krishnamurthy, Vijaya Bhatt, Kam Newman, James O Armitage, Mojtaba Akhtari

  e2013068

  2013-11-04

  https://doi.org/10.4084/mjhid.2013.068

  2579

  PDF: 1297

  HTML: 3921

• High Prevalence of Antiphospholipid Antibodies in Children with Non-Transfusion Dependent Thalassemia and Possible Correlations with Microparticles Antiphospholipid Antibodies and Thalassemia in children

  Jitlada Chinsuwan, Phatchanat Klaihmon, Praguywan Kadegasem, Ampaiwan Chuansumrit, Anucha Soisamrong, Kovit Pattanapanyasat, Pakawan Wongwerawattanakoon, Nongnuch Sirachainan

  e2020071

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.071

  1182

  PDF: 694

  HTML: 333

• Antibody response to breakthrough SARS-CoV-2 infection in “booster” vaccinated patients with multiple myeloma according to B/T/NK lymphocyte absolute counts and anti-CD38 treatments

  NICOLA SGHERZA, Anna Mestice, Angela Maria Vittoria Larocca, Pellegrino Musto

  e2024022

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.022

  874

  PDF: 1230

  HTML: 112

• APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE

  Alberto L. García-Basteiro, Quique Bassat, Pedro L. Alonso

  e2012015

  2012-03-10

  https://doi.org/10.4084/mjhid.2012.015

  2774

  PDF: 1061

  HTML: 15157

• NOVEL DRUGS IN FOLLICULAR LYMPHOMA

  Giuseppe Rossi, Antonella Anastasia

  e2016061

  2016-11-01

  https://doi.org/10.4084/mjhid.2016.061

  6001

  PDF: 1626

  HTML: 1687

  Untitled: 287

• IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS

  Alana Kennedy-Nasser, Catherine Bollard, Helen Heslop

  e2009010

  2009-11-13

  https://doi.org/10.4084/mjhid.2009.010

  1325

  PDF: 658

  HTML: 6943

• PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma

  Ugo Testa; Giuseppe G.M. Leone

  e2025005

  2024-12-31

  https://doi.org/10.4084/MJHID.2025.005

  2647

  HTML: 364

  PDF: 987

• IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS

  Efterpi Kostareli, Maria Gounari, Andreas Agathangelidis, Kostas Stamatopoulos

  e2012052

  2012-08-09

  https://doi.org/10.4084/mjhid.2012.052

  3320

  PDF: 972

  HTML: 7327

  Kost Fig1: 233

  Kost Fig 2: 220

  Kost Fig3: 236

  Kost Fig 4: 246

  Kost Fig5: 244

  Kost fig 6: 232

• LIGHT CHAIN AMYLOIDOSIS

  Paolo Milani, Giampaolo Merlini, Giovanni Palladini

  e2018022

  2018-03-01

  https://doi.org/10.4084/mjhid.2018.022

  6573

  PDF: 2503

  HTML: 1585

• Guest Editor: Pellegrino Musto AN UPDATE OF THE APPROPRIATE SEQUENCING FOR SALVAGE THERAPIES IN MULTIPLE MYELOMA

  Gregorio Barila', Francesca Rezzonico, Laura Pavan, Alessandro Corso, Renato Zambello

  e2025043

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.043

  1305

  PDF: 1046

  HTML: 526

• MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT

  Alfredo Marzano

  e2009025

  https://doi.org/10.4084/mjhid.2009.025

  946

  PDF: 527

  HTML: 1328

• WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND CLINICAL PROBLEMS

  Michele Bibas, Shayna Sarosiek, Jorge J. Castillo

  e2024061

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.061

  3200

  PDF: 3437

  HTML: 809

• HEMATOLOGICAL ABNORMALITIES BEYOND LYMPHOCYTOSIS DURING INFECTIOUS MONONUCLEOSIS: EPSTEIN-BARR VIRUS-INDUCED THROMBOCYTOPENIA THROMBOCYTOPENIA DURING INFECTIOUS MONONUCLEOSIS

  Arturo Gonzalez Quintela, Emilio Paez-Guillan, Joaquin Campos-Franco, Rosario Alende

  e2023023

  2023-02-28

  https://doi.org/10.4084/MJHID.2023.023

  2537

  HTML: 693

  PDF: 1451

• PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES

  Stefano Lancellotti, Maria Basso, Raimondo De Cristofaro

  e2013058

  2013-09-01

  https://doi.org/10.4084/mjhid.2013.058

  3656

  PDF: 1262

  HTML: 24298

• PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS

  Mario Sabatelli, Luca Laurenti, Marco Luigetti

  e2018057

  2018-09-01

  https://doi.org/10.4084/mjhid.2018.057

  1917

  PDF: 951

  HTML: 481

  Fig1: 290

  Fig.2: 316

  Fig. 3: 247

  Fig. 5: 268

  Fig. 4: 281

• CLINICAL AND LABORATORY CHARACTERISTICS OF DENGUE-ORIENTI TSUTSUGAMUSHI CO-INFECTION FROM A TERTIARY CARE CENTER IN SOUTH INDIA

  Aneesh Basheer, Nayyar Iqbal, Sudhagar Mookkappan, Patricia Anitha, Shashikala Nair, Reba Kanungo, Ravichandran Kandasamy

  e2016028

  2016-06-16

  https://doi.org/10.4084/mjhid.2016.028

  5206

  PDF: 994

  HTML: 1696

• IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA: PATHOPHYSIOLOGY, DIAGNOSIS AND OPEN ISSUES

  Silvia Maria Trisolini, Alessandro Laganà, Saveria Capria

  e2024060

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.060

  2737

  PDF: 2003

  HTML: 191

• Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era

  Serena Vita, Emanuela Giacobini, Patrizia De Marco, Martina Rueca, Cesare Ernesto Maria Gruber, Alessia Beccacece, Laura Scorzolini, Valentina Mazzotta, Carmen Pinnetti, Priscilla Caputi, Daniele Focosi, Enrico Girardi, Andrea Antinori, Fabrizio Maggi, Alessandra D'Abramo, Emanuele Nicastri, Spallanzani COVID-19 case Investigation Team

  e2024043

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.043

  1418

  PDF: 1043

  HTML: 112

• COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.

  Federico Mercolini, Simone Cesaro

  e2022009

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.009

  2879

  PDF: 1025

  HTML: 610

• Humoral immune response after anti-SARS-CoV-2 vaccine “booster” dose in patients with monoclonal gammopathy of undetermined significance (MGUS)

  NICOLA SGHERZA, Paola Curci, Rita Rizzi, Angela Maria Vittoria Larocca, Luigi Vimercati, Silvio Tafuri, Maria Chironna, Pellegrino Musto

  e2023011

  2023-01-01

  https://doi.org/10.4084/MJHID.2023.011

  1114

  PDF: 1060

  HTML: 528

• SYSTEMIC FRONT LINE THERAPY OF FOLLICULAR LYMPHOMA: WHEN, TO WHOM AND HOW

  Francesca Pavanello, Sara Steffanoni, Michele Ghielmini, Emanuele Zucca

  e2016062

  2016-11-06

  https://doi.org/10.4084/mjhid.2016.062

  3993

  PDF: 1163

  HTML: 2579

• CURRENT STRATEGIES FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

  Juliana Maria Camargos Rocha, Sandra Guerra Xavier, Marcelo Eduardo Lima Souza, Juliana Godoy Assumpção, Mitiko Murao, Benigna Maria Oliveira

  e2016024

  2016-04-10

  https://doi.org/10.4084/mjhid.2016.024

  4868

  PDF: 1428

  HTML: 4982

• THE IMPACT OF CHEMOTHERAPY AFTER PEDIATRIC MALIGNANCY ON HUMORAL IMMUNITY TO VACCINE-PREVENTABLE DISEASES

  Chiara Garonzi, Rita Balter, Gloria Tridello, Anna Pegoraro, Manuela Pegoraro, Monia Pacenti, Novella Scattolo, Simone Cesaro

  e2020014

  2020-02-26

  https://doi.org/10.4084/mjhid.2020.014

  1807

  PDF: 1066

  HTML: 345

• Seroprevalence of anti SARS-CoV2 antibodies in Umbrian persons living with HIV SARS-CoV-2 and HIV

  chiara papalini, Francesco Paciosi, Elisabetta Schiaroli, Sara Pierucci, chiara Busti, Silvia Bozza, Antonella Mencacci, Daniela Francisci

  e2020080

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.080

  1081

  PDF: 856

  HTML: 471

• APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA

  Tadeusz Robak

  e2010011

  2010-05-07

  https://doi.org/10.4084/mjhid.2010.011

  1772

  PDF: 710

  HTML: 2457